|
|
|
|
SEC to Investigate Sequenom
The Securities and Exchange Commission has initiated an investigation into employee data mishandling at Sequenom, according to a June 30 regulatory filing.In April, the San Diego-based maker of prenatal tests revealed that it could no...
|
|
|
Familiar Name Joins Fight Against Cancer
Startup veteran Harry Gruber is raising money for Tocagen, his latest venture in biotech.| File photo Serial entrepreneur Harry Gruber is at it again, starting yet another tech company, this one aimed at developing treatments for...
|
|
|
Cutting-Edge Nanotech Devices Could Fight Disease From Inside the Body
Sarah Blair is a breast cancer surgeon who's involved in nanotechnology research at UC San Diego.The researchers are attempting to find solutions that would reduce the need for follow-up surgeries. | Stephen Whalen It's the stuff of...
|
|
|
Next Step for Nanotech: Treating Cancer in Clinical Studies
Michael Sailor Michael Sailor, a UC San Diego chemistry and biochemistry professor, leads a government-funded laboratory where researchers study nano-sized technologies like nanoworms, which swim through the bloodstream honing in on...
|
|
|
Invetech Builds Up Sales Close to Life Sciences Clients
By MARION WEBB Richard Grant, who heads up scientific instrument and automation systems developer Invetech in Mira Mesa, has good reason to remain optimistic about its future.Since the Melbourne, Australia-based business opened up its...
|
|
|
Inventors Mull Consequences Of Patent Reform Legislation
John Wetherell As patent reform legislation makes its way through Congress, San Diego's biotech companies are bracing for major changes to the patent application process and how they protect their discoveries.Under rules proposed in the...
|
|
|
Biotech Profile - Tina S. Nova
Tina Nova is president and CEO of Carlsbad-based Genoptix.The firm services the needs of community physicians who are working to identify and diagnose complex blood-based diseases, such as leukemia and lymphoma, by providing physician...
|
|
|
Biotech Profile - Joel Martin
Joel Martin is president and CEO of Altair Therapeutics, which is developing novel therapeutics to treat human respiratory diseases.Altairs lead product is AIR645, the first in a class of inhaled drugs that incorporate second-generation...
|
|
|
Arena Gets $100M Loan
Weight loss drug maker Arena Pharmaceuticals said June 18 it secured a loan worth $100 million from a New York-based health care investment firm.The money will provide the San Diego biotech with support in developing its experimental drug...
|
|
|
Trius Therapeutics Trying to Win Battle Against 'Superbug'
The race to approve a new antibiotic for treating the drug-resistant superbug known as MRSA intensified last week when Trius Therapeutics revealed data showing its experimental drug has potential for curing severe skin infections.The drug...
|
